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Introduction {#sec1.1}
------------

Viruses are obligatory intracellular parasites; therefore, their replication (and the pathogenic consequences of infection) depends critically on the ability to transmit their genomes from infected to noninfected host organisms and from infected to uninfected cells. The small size, structural simplicity, and lack of any metabolic or motile activities severely limit the types of processes that virus particles can themselves undertake to promote the transfer process. As passive, inert particles, they have evolved to exploit the behavior and the physiology of their hosts.

At the cell level, this is manifested in the activation of endogenous cellular responses that provide assistance to viruses so that they can cross membranes and other barriers and deliver their genes into the cytosol or the nucleus. Recent studies indicate that cells offer a variety of endocytosis, trafficking, and sorting mechanisms that animal viruses can take. Moreover, viruses have become valuable tools to study some of these processes. Here, we review the general concepts in virus entry and discuss some of the emerging issues.

Virus Particles as Devices for Targeted Gene Transfer {#sec1.2}
-----------------------------------------------------

A viral particle is composed of nucleic acids (RNA or DNA), protein, and, in the case of enveloped viruses, membrane lipids. The proteins include structural components, such as capsid proteins; matrix proteins; membrane glycoproteins; and, in many cases, accessory proteins such as reverse transcriptases, RNA polymerases, kinases, and proteases. One or more shells of protein protect the RNA or DNA genome in the so-called capsid, which is often helical or icosahedral. Enveloped viruses have, in addition, a lipid bilayer membrane that serves to protect the capsid and the genome and operates as a "transport vesicle" during cell-to-cell transmission.

Transmission involves three main stages: the assembly of virus particles in infected cells, their release to the extracellular space, and entry into a new cell. Nonenveloped virus particles and the capsids of enveloped viruses are assembled in the cytosol or the nucleus of the infected cell. The lipid bilayer membrane (envelope) of enveloped viruses is acquired during a budding process through a cellular membrane. With few exceptions, the key proteins in the capsid and the envelope are encoded by the viral genome.

Given that the components of the virus particle are often synthesized in different parts of the cell, the assembly of a particle is a remarkable example of coordinated molecular sorting. The assembly processes involve the establishment of a complex network of specific interactions that bring the relevant viral components together into a particle with precise stoichiometry and geometry and with the exclusion of most cellular components. That all this is possible with the limited genetic information contained in viral genomes is impressive. It serves as a testament to the viruses\' ingenious structural designs and the generous assistance of the cell.

Enveloped particles leave the infected cell inconspicuously by budding and secretion. Nonenveloped viruses are usually thought to undergo release through cell lysis, but some may escape by secretory mechanisms after budding into membrane bound compartments and then losing their membrane ([@bib2]). Others may subvert cellular autophagy pathways to gain access to exocytic organelles ([@bib32]).

The particles released from cells are stable structures crosslinked by networks of intermolecular interactions. They are resistant to the stresses encountered in the extracellular space during transmission from cell to cell and host to host. However, at the same time, the assembly and maturation program has made sure that the particles can fall apart at a moment\'s notice during entry into a new cell. The reversibility of assembly is important to liberate the genome in infectious form and release the accessory proteins. Many of the stabilizing interactions in the particle must be undone: the envelope must be shed, the capsid opened, and the nucleic acids decondensed. To make this possible, the entire virus particle or specific proteins in it are locked in metastable conformations and poised to undergo major conformational changes when triggered by appropriate cues during entry ([@bib83]). The uncoating program is thus built into the virion during assembly, allowing major transformations in the particle without the need for external energy.

Like assembly, entry and uncoating typically occur in several tightly controlled, consecutive steps. These steps, shown in [Figure 1](#fig1){ref-type="fig"} for a virus that enters via endocytosis and moves to the nucleus (e.g., an adeno- or polyomavirus), start with events at the cell surface and end with the decondensation of the genome at the site of replication. As the virus progresses in its entry program, it undergoes changes that lead to events such as penetration, capsid destabilization, and uncoating of the genome. Many of these changes result from conformational alterations in metastable viral structures. They are triggered by receptor binding, exposure to low pH, reentry into a reducing environment, enzyme-induced covalent modifications, and other cellular cues ([@bib19], [@bib26], [@bib29], [@bib77]). Viruses exploit such signals not only to induce changes in the particle and dissociation of protein subunits but also to coordinate movement from one compartment and location in the cell to another, ensuring that each step in the uncoating program occurs at the right point in the sequence, at the right time, and in the right place.Figure 1Steps in the Endocytic Entry Program of a Typical Animal VirusWhether enveloped or nonenveloped, many viruses depend on the host cell\'s endocytic pathways for entry. They follow a multistep entry and uncoating program that allows them to move from the cell periphery to the perinuclear space. In this example, the virus proceeds to deliver its uncoated genome into the nucleoplasm. The interaction between the virus and the host cell starts with virus binding to attachment factors and receptors on the cell surface, followed by lateral movement of the virus-receptor complexes and the induction of signals that result in the endocytic internalization of the virus particle. After vesicular trafficking and delivery into the lumen of endosomes, caveosomes, or the ER, a change in the virus conformation is induced by cellular cues. This alteration results in the penetration of the virus or its capsids through the vacuole membrane into the cytosolic compartment. Enveloped viruses use membrane fusion for penetration, whereas nonenveloped viruses induce lysis or pore formation. After targeting and transport along microtubules, the virus or the capsid binds, as in this example, to the nuclear pore complex, undergoes a final conversion, and releases the viral genome into the nucleus. The details in the entry program vary for different viruses and cell types, but many of the key steps shown here are general.

Although the incoming viruses depend on cues from the cell, the cell also responds to signals induced by the virus. Simply by binding to surface receptors, and perhaps by clustering them, many viruses "knock at the door" of the cell by activating cellular signaling cascades. This is often essential because it results in the local activation of ligand-triggered processes that viruses require for entry, such as caveolar/raft endocytosis, clathrin-coat assembly, and actin-cortex dissociation. This aspect of virus entry is complex but increasingly central for understanding the infection process.

Virus Receptors {#sec1.3}
---------------

In order to infect, viruses must first bind to the cell surface. The surface structures that they bind to are of two general types depending on the functional consequences of the interaction. Attachment factors serve to bind the particles and thus help to concentrate viruses on the cell surface. Such interactions can be relatively nonspecific. Often they involve interactions with heparan sulfate or other carbohydrate structures on the cell surface ([@bib94], [@bib97], [@bib101]).

Unlike attachment factors, virus receptors actively promote entry. They can do so by initiating conformational changes in the virus particle, by activating signaling pathways, and by promoting endocytic internalization. Often the receptors accompany the virus into the cell during endocytic uptake and may then play a role intracellularly in the penetration reaction.

Given that the interactions are usually highly specific, the presence of receptors determines to a large degree which cell types and species can be infected. These interactions and the molecules involved are of crucial importance for understanding not only the mechanisms of entry but also the biology of infection and pathogenesis. In recent years, hundreds of attachment factors and receptors for different viruses have been identified, resulting in a large body of valuable information ([@bib101]). The crystal structures of several viruses and viral proteins bound to receptors have also been solved ([@bib41], [@bib67], [@bib76], [@bib84]). Within the scope of this review, it is not possible to discuss the attachment factors and receptors in depth; however, it is important to emphasize that the list encompasses a wide variety of different proteins, lipids, and carbohydrates. Included are ion transporters, adhesion factors, signaling proteins, and a variety of other cell-surface receptors. Proteoglycans and glycolipids are commonly used as virus receptors or attachment factors ([@bib101]). Moreover, influenza viruses and some paramyxoviruses have spike glycoproteins with lectin domains that bind to sialic acid, and the major coat protein of polyomaviruses, VP1, binds to the glycan moiety of specific gangliosides ([@bib76], [@bib81], [@bib91]).

Although individual interactions between viruses and their receptors are specific, they are often of low affinity. However, the avidity increase resulting from multiple receptor binding sites on virus particles often guarantees nearly irreversible binding. Moreover, multisite binding is likely to cluster receptor proteins, which in turn may activate signaling pathways and/or recruitment to endocytic structures (see below).

Numerous viruses are known to use more than one type of receptor, either in parallel or in series. The consecutive use of CD4 and a chemokine receptor by the human immunodeficiency virus (HIV type 1) is a well-studied example of the latter. In this case, the two receptors are needed to induce major conformational changes in the HIV envelope protein that initiate membrane fusion ([@bib4]). Interestingly, HIV-1 can also bind to glycosylceramides and heparan sulfate, interactions that may facilitate the initial recruitment of virus to susceptible cells ([@bib46], [@bib94]). Moreover, the presence of specific glycosphingolipids in the target cell membrane can enhance CD4/coreceptor-dependent fusion ([@bib65]). Viruses, in particular those that undergo rapid mutation, are also known to be able to switch receptors ([@bib8], [@bib40]) or adapt to use alternative receptors when the primary receptor is absent ([@bib97]). This is one of the risks posed by the current avian influenza epidemic: the avian hemagglutinin glycoprotein may, through mutations, evolve to interact more potently with glycoconjugates on human cells.

The entry of coxsackie B virus provides an interesting example of how viruses can exploit the different properties of cell-surface receptors to bring about stepwise entry. In this case, the host cells are epithelial cells that grow in tight monolayers. Coxsackie B viruses are human picornaviruses that cause meningitis and myocarditis. They are simple, nonenveloped RNA viruses that replicate in the cytosol and do not need low pH for penetration. They share an essential receptor molecule with adenoviruses, a glycoprotein called CAR (the coxsackie and adenovirus receptor) ([@bib102]). In epithelial cells, CAR is a component of tight junctions and is therefore not accessible to incoming viruses from the apical side. A recent study addressed the question of how the virus gains access to its receptor, i.e., how it breaches the epithelial barrier ([@bib13]).

The starting point for the study was the observation that many coxsackie B strains interact with a coreceptor present on the apical surface of epithelial cells, the decay-accelerating factor (DAF, a GPI-anchored protein) ([@bib73]). Virus binding leads to crosslinking of DAF molecules, inclusion into lipid rafts, and activation of the tyrosine kinase c-Abl ([@bib13]). Once activated, c-Abl was found to activate the Rho-family small GTPase Rac, which in turn induced a reorganization of the actin cytoskeleton and promoted transfer of bound viruses from the apical surface to the tight-junction region of the cell. This made it possible for the virus to associate with CAR and for CAR to induce a conformational change in the virus particle, an obligatory step in picornavirus uncoating and entry ([@bib29]). To release its RNA into the cytoplasm, the modified particles were then internalized by caveolar endocytosis activated by phosphorylation of Tyr14 in caveolin-1 by Fyn, a member of the Src family of nonreceptor tyrosine kinases. The detailed route taken by the virus inside the cell remains unclear at this point, but the final release of the viral RNA into the cytosol is likely to occur in the endoplasmic reticulum (ER).

This study elegantly demonstrates how a virus exploits multiple cellular receptors and functions to overcome the obstacles it encounters during entry into cells. In this particular cellular context, the coreceptor is needed to overcome the inaccessibility of the main receptor. As discussed below, the signaling cascades are often important in both entry steps and downstream activation of the cytoskeleton and endocytic machinery.

Virus-Induced Signaling {#sec1.4}
-----------------------

It is apparent that many viruses make use of the cell\'s signaling pathways during entry. This was first recognized for adenoviruses, which use CAR as a primary receptor and integrins as coreceptors ([@bib45], [@bib54]). Nemerow and coworkers demonstrated that the interaction between adenovirus pentons (protein complexes which together with the hexons make up the adenovirus capsid) and integrins activates phosphatidylinositol 3-kinase (PI(3)K), which in turn activates Rac and Cdc42, resulting in the polymerization of actin- and clathrin-mediated endocytosis of the virus. Activation of many different signaling pathways has since been described with the involvement of a variety of factors, including serine/threonine, tyrosine, and PI kinases; phosphatases; and a variety of small GTPases (including Arf, Rab, and Rho family members) ([@bib24], [@bib62]).

Viruses use signaling activities to induce changes in the cell that promote viral entry and early cytoplasmic events, as well as to optimize later processes in the replication cycle. Initially, the viruses need to make their presence on the cell surface known so that the cell can launch an endocytic response to bring them in. For example, the internalization of SV40 by caveolar/raft endocytosis is regulated by at least five different kinases ([@bib62]). Inhibition of tyrosine kinases in particular blocks internalization and dramatically reduces infection ([@bib12], [@bib60]). In other cases, a virus may need to induce lateral movement along the membrane. This can be seen very dramatically when viruses such as murine leukemia virus and HIV-1 bind to filopodia and proceed to "surf" on the outside of these structures toward the cell body ([@bib44]). As discussed above, lateral movement is also needed for coxsackie B viruses to reach the CAR receptor in epithelial cells, and this movement requires activation of c-Abl following virus-induced crosslinking of DAF ([@bib13]).

The signals can be generated in several ways. The viruses may activate cellular signaling molecules directly by using them as receptors. This may be why so many viruses bind integrins. Viruses may also induce signaling by clustering specific cell-surface proteins or lipids. Interestingly, a number of viruses use GPI-anchored proteins and gangliosides, which are only associated with the outer leaflet of the plasma membrane, as their receptors. That this often leads to activation of tyrosine kinases on the cytosolic side may be related to the fact that the GPI-anchored proteins and gangliosides become lipid-raft associated when clustered ([@bib13], [@bib57], [@bib58], [@bib60], [@bib71]). Being dually acylated, some Src-family kinases (though not Src itself) are also enriched in lipid-raft microdomains, but on the cytoplasmic surface of the membrane. Accordingly, there is increasing evidence that many viruses associate with lipid rafts to initiate intracellular signaling ([@bib13], [@bib16], [@bib56]).

Virus Penetration: The Cell Surface versus Intracellular Membranes {#sec1.5}
------------------------------------------------------------------

The transfer of the genome and accessory proteins through the barrier of a cellular membrane into the cytosol is called penetration. For enveloped viruses, penetration involves membrane fusion, and, for nonenveloped viruses, it involves pore formation or membrane lysis. The molecular mechanisms of viral membrane fusion are beginning to be understood in increasingly fine detail but will not be considered here ([@bib19], [@bib26], [@bib37]). For the most part, the penetration mechanisms of nonenveloped viruses are less well understood. However, recent single-particle cryo-EM analysis of polioviruses bound to receptor-containing membranes has started to provide detailed information on the structural changes involved in picornavirus penetration and the organization of poliovirus-induced membrane pores through which the viral RNA is believed to enter the cytoplasm ([@bib7]).

The cellular membrane penetrated during virus entry is either the plasma membrane or the limiting membrane of an intracellular organelle, the lumen of which viruses reach after endocytosis. In all known cases, the viruses or their capsids penetrate first into the cytosol. Most RNA viruses (though not all) replicate in the cytosol, often in contact with specific organelles ([@bib69]). With the exception of poxviruses and iridoviruses, DNA viruses and their capsids are subsequently transported to the nucleus for replication.

It has been known for a long time that certain enveloped viruses such as herpes simplex virus 1 (HSV-1); Sendai virus; and many retroviruses, including HIV, have pH-independent fusion proteins and can therefore penetrate into cells by fusing directly with the plasma membrane. It is generally assumed that fusion events at the plasma membrane lead to productive infection, although this is difficult to prove because virus particles are also continuously endocytosed. Among nonenveloped viruses, several families, including some picornaviruses (such as polio) and polyomaviruses, do not require low pH for penetration. While many of these are known to require endocytosis for penetration, it has been argued that some may penetrate directly through the plasma membrane, though this remains contentious ([@bib29]).

However, if we view the whole spectrum of viruses, the majority do need endocytic internalization for penetration and productive infection, most likely because endocytosis offers real advantages. Viruses that are ferried into cells inside endocytic vesicles can move deep into the cytoplasm, bypassing many of the barriers associated with the membrane cortex and cytosolic crowding ([@bib49]) and exploiting the molecular motors that are normally recruited to endocytic vesicles ([@bib18]). A dependence on low pH for penetration allows viruses to use the decreasing pH of endocytic organelles as a cue to activate the penetration reactions and allows viral escape to the cytoplasm at specific locations or before the virus is delivered to the hydrolytic lysosomes ([@bib27]). In addition, no viral components remain on the cell surface after penetration for detection by the host\'s immune defenses.

Virus Penetration through Clathrin-Mediated Endocytosis {#sec1.6}
-------------------------------------------------------

Of the endocytic pathways taken by viruses, the most commonly used is the clathrin-mediated endocytic route ( [Figure 2](#fig2){ref-type="fig"}C and [Figures 3](#fig3){ref-type="fig"}A and 3B). It transports incoming viruses together with their receptors into early and late endosomes. Clathrin-mediated endocytosis is a continuous process, and, for virus entry, it is usually rapid and efficient ([@bib50]). The incoming viruses are often exposed to the acidic milieu of endosomes within minutes after internalization, and many respond to the pH drop by undergoing changes that lead to penetration. Depending on the pH threshold, the site of penetration is either the early (pH 6.5 to 6.0) or the late endosome (pH 6.0 to 5.5). In some cases, such as for Ebola virus, SARS coronavirus, and the nonenveloped mammalian reoviruses, acidic pH alone is not sufficient to induce fusion, and proteolytic cleavages in viral proteins by acid-dependent endosomal proteases, in particular cathepsins L and B, are needed to trigger the change to the penetration-competent state ([@bib10], [@bib20], [@bib75]). For avian leukosis virus, both interaction of the viral envelope protein with a specific receptor ([@bib14], [@bib28]) and low pH ([@bib53]) are required for fusion.Figure 2Endocytic Pathways Used by VirusesIn mammalian cells, many different mechanisms are available for the endocytic internalization of virus particles. Some of these mechanisms, such as clathrin-mediated endocytosis, are ongoing, whereas others, such as caveolae, are ligand and cargo induced. Currently, there is evidence for six pathways.(A) Macropinocytosis is involved in the entry of adenoviruses.(B) A clathrin-independent pathway from the plasma membrane has been shown to exist for influenza virus and arenaviruses.(C) The clathrin-mediated pathway is the most commonly observed uptake pathway for viruses. The viruses are transported via early endosomes to late endosomes and eventually to lysosomes.(D) The caveolar pathway is one of several closely related, cholesterol-dependent pathways that bring viruses including SV40, coxsackie B, mouse polyoma, and Echo 1 to caveosomes, from which many of them continue, by a second vesicle transport step, to the ER.(E) A cholesterol-dependent endocytic pathway devoid of clathrin and caveolin-1, used by polyomavirus and SV40.(F) A pathway similar to (D) except dependent on dynamin-2. It is used by Echo virus 1.Depending on the virus and cell type, penetration reactions occur in five locations: the plasma membrane, early and late endosomes, caveosomes, and the ER. Note that the additional endocytic mechanism of phagocytosis also operates in many cells but has not as yet been linked to virus entry and is not included here.Figure 3Electron Micrographs Showing Virus Internalization by Clathrin- or Caveolar/Raft-Mediated Endocytosis(A and B) Semliki Forest virus, a 70 nm diameter enveloped alphavirus, is internalized by clathrin-coated pits (A) and vesicles (B) for endocytosis and infection. Here, the virus is interacting with a BHK-21 cell.(C and D) Simian virus 40, a small 50 nm diameter nonenveloped DNA virus, binds to gangliosides in the plasma membrane of CV-1 cells and enters via caveolae (C) and tight-fitting small vesicles. The viruses are transported through caveosomes to the ER, where many accumulate in smooth membrane domains (D). Scale bar in (A) and (C) = 100 nm, (B) = 200 nm, and (D) = 250 nm. (A), (C), and (D) are courtesy of J. Kartenbeck and A.H. (B) is reproduced from [@bib28], The Journal of Cell Biology, 1980, volume 84, pp. 404--420 by copyright permission of The Rockefeller University Press.

Single-particle tracking of influenza virus in cultured simian kidney epithelial cells shows that, although 60% of the particles enter via clathrin-coated pits, 40% use a clathrin-independent pathway ([@bib68]) ([Figure 2](#fig2){ref-type="fig"}B). Surprisingly, of those that use the clathrin-dependent pathway, only 5% associate with preexisting clathrin-coated domains in the membrane; the majority enter via coated pits that assemble underneath the surface bound viral particles. This implies induction of transmembrane signaling by the receptor bound virus particles. A similar induction of coated-pit formation has also been observed for reovirus and Semliki Forest virus (SFV) ([@bib21]; A. Vonderheit and A.H., unpublished data); whether this represents recruitment of clathrin-coat components to the clustered cytoplasmic domains of viral receptor proteins or a more complex signaling cascade leading to clathrin recruitment is unclear.

Endocytic clathrin-coated vesicles deliver their contents to early endosomes ([Figure 2](#fig2){ref-type="fig"}C). These organelles, though morphologically complex, have usually been considered to be a homogeneous population. However, there is increasing evidence that viruses and other endocytosed cargo are selectively targeted to specific populations of endosomes ([@bib39]). For example, the early endosomes that receive the incoming influenza viruses belong to a population that rapidly relocates the viruses, by microtubule-mediated transport, to the perinuclear region, where penetration occurs by fusion ([@bib42]). SFV fuses soon after delivery to Rab5 and EEA1-positive early endosomes, but the fused virus is then transported in Rab7-positive carriers to late endosomes ([@bib98]). There is also a recent observation that vesicular stomatitis virus (VSV) may fuse with the internal membrane vesicles of multivesicular endosomes and that these internal membranes subsequently fuse with the limiting membrane of late endosomes to release the viral RNA to the cytoplasm ([@bib43]). In this case, penetration would involve two membrane fusion events, the first mediated by the viral envelope protein and the second by an as yet uncharacterized cellular mechanism. Interestingly, the endocytic uptake and penetration of anthrax toxin also appears to involve a two-step process, the first involving interaction of the toxin with the internal membranes of a multivesicular endosome and the second a back fusion of these membranes with the endosome-limiting membrane ([@bib1]).

The complexity of the clathrin-mediated endocytic pathway is illustrated by the increasing number of alternative cofactors, adaptors, and tethering proteins that are involved in the formation of clathrin-coated pits and vesicles ([@bib66]). Using small interfering RNA (siRNA) silencing screens, more than 90 different kinases have recently been shown to regulate the clathrin-mediated internalization and early steps of infection of HeLa cells by VSV ([@bib62]). These kinases belong to many different classes, including regulators of the cytoskeleton, cell cycle, cell growth, and membrane trafficking. They either increase or decrease the efficiency of VSV entry and early steps in the infection cycle. Many of the kinases were shown to have a direct effect on the clathrin-mediated endocytosis of other ligands.

Virus Penetration Following Clathrin-Independent Endocytosis {#sec1.7}
------------------------------------------------------------

That some viruses use clathrin-independent pathways for endocytosis and infection is now widely accepted. The best studied of these are the caveolar/raft pathways first observed for SV40, a simple nonenveloped DNA virus ([@bib3], [@bib36], [@bib80]). The caveolar/raft pathways, of which there are at least three related variants ([Figures 2](#fig2){ref-type="fig"}D--2F), seem to specialize in the internalization of lipids including cholesterol, GPI-anchored proteins, and components of cholesterol-rich microdomains (lipid rafts). Caveolae are also involved in the transcytosis of serum components in endothelial cells, and many cargo molecules of these pathways seem to have a role in signaling.

The capsids of SV40 and the related polyomavirus are composed of 72 homopentameric VP1 protein units that resemble cholera toxin B chain pentamers ([@bib82], [@bib81]). Like cholera toxin, these viruses bind to the sugar moiety of gangliosides and enter cells via caveolar/raft pathways that are dependent on cholesterol ([Figures 2](#fig2){ref-type="fig"}D and 2E) and the activation of tyrosine-kinase signaling cascades ([@bib3], [@bib59], [@bib78], [@bib80], [@bib91]). Activation involves tyrosine kinases, PI kinases, and raft lipids. Dynamin 2, actin, caveolin-1, and Rho GTPases are also involved, depending on the virus and the cell type ([@bib60]). Internalization occurs via caveolae that are activated for long-distance transport in the cytosol or via small vesicles that lack caveolin-1 ([@bib16], [@bib86]) ([Figures 3](#fig3){ref-type="fig"}C and 3D).

The caveolar/raft pathway takes the majority of internalized viruses first to pH-neutral organelles in the cytoplasm called caveosomes ([Figure 2](#fig2){ref-type="fig"}D). Following a second activation step, the virions are then transported by caveolin-free, microtubule-dependent vesicles trafficking to the ER, where penetration occurs ([@bib59]). A recent study suggests that a lumenal ER protein, ERp29, a thioredoxin homolog without thiol oxidoreductase activity, facilitates penetration of polyomavirus by exposing the hydrophobic, C-terminal arm of VP1 ([@bib47]). In the case of SV40, we have found that the redox conditions in the ER, as well as two thiol oxidoreductases, PDI and ERp57, are important for SV40 uncoating and infection (M. Schelhaas, L. Pelkmans, and A.H., unpublished data). Since siRNA silencing of derlin 1, a protein linked to the reverse translocation of substrates for ER-associated protein degradation (ERAD), inhibits infection, it is likely that components of the ERAD pathway play a central role in SV40 penetration from the ER. Interestingly, a similar mechanism may explain how the cholera toxin A chains penetrate into the cytosol ([@bib90]).

RNAi silencing screens with the entire human kinome have demonstrated that, in HeLa cells, the caveolar/raft pathways that mediate SV40 entry depend on some 80 different kinases. The set of kinases show only partial overlap with those that regulate the clathrin-mediated entry of VSV ([@bib62]). Interestingly, many of the kinases involved in SV40 entry are known to have functions in integrin signaling and actin regulation.

Other viruses that use caveolar/raft endocytosis include Echo 1, a picornavirus that binds to integrins, and coxsackie B in human Caco-2 epithelial cells ([@bib13], [@bib64]). For Echo 1 virus, caveolar/raft uptake and entry require signaling that involves protein kinase C, and penetration seems to occur in caveosomes without the involvement of the ER ([@bib63], [@bib95]).

In addition to these pathways, there is increasing evidence for clathrin-independent pathways of virus entry into the endosomal system ([Figure 2](#fig2){ref-type="fig"}B). Such a pathway has been observed for the arenavirus lymphocytic choriomeningitis virus (LCMV) and, as already mentioned, for a fraction of incoming influenza viruses ([@bib6], [@bib68], [@bib74]). The molecular mechanisms involved in the pathway (or pathways) are not understood. By contrast, following binding to CAR and αv integrin coreceptors, adenovirus type 2 (Ad2) activates an actin-dependent process classified as macropinocytosis ([Figure 2](#fig2){ref-type="fig"}A), but virus endocytosis occurs via clathrin-coated pits. Inhibition of macropinocytosis inhibits virus entry, but how exactly this endocytic process influences virus penetration is unclear ([@bib52]). Although the formation of primary vesicles displays great heterogeneity, the subsequent steps inside the cell involve either endosomes or caveosomes and require cholesterol ([@bib31]). That these two organelle classes are not entirely independent of each other is shown by their regulation through a small subset of common kinases and by the observation that cargo can be transferred between them ([@bib61]).

Together with bacterial toxins such as cholera, anthrax, and Shiga toxin, viruses are emerging as valuable ligands for charting the various ligand-inducible pathways of endocytosis. The spectrum of pathways is often redundant and cell-type specific. Differences in sensitivity to inhibitors, expression of dominant-negative mutants, and live-cell microscopy show that the pathways differ in their kinetics and their dependence on host-cell kinases; dynamins; Rac-, Rab-, and Arf-family GTPases; actin and tubulin; and cholesterol. The pathways are also likely to be physiologically regulated (e.g., the upregulation of compensatory pathways when clathrin-mediated endocytosis is inhibited; [@bib15]). This may be one reason why viruses such as SV40 and influenza can use several different pathways, enabling them to infect a wide range of cells under various conditions. The question arises as to whether the pathways that have been identified in tissue culture systems, in some cases under unusual experimental conditions, occur in the relevant cells in vivo or whether there are additional endocytic entry mechanisms still to be discovered.

It will take some effort to define how many different endocytic pathways operate in cells and their normal functional activities. Further analysis using siRNA screens, with larger siRNA libraries and other viruses, may allow the identification of unique sets of proteins that are required for the entry of viruses that use a specific endocytic mechanism, thus providing a genetic fingerprint for each pathway. Such analyses should demonstrate whether these different pathways involve distinct molecular mechanisms or whether overlapping sets of proteins mediate several variants of essentially a single endocytic mechanism.

Virus Transmission: Cell-free versus Cell-Cell Infection {#sec1.8}
--------------------------------------------------------

The existence of pH-independent fusion proteins has an important consequence for some viruses. When these proteins are expressed on the cell surface, they can allow fusion of the infected cell with neighboring noninfected cells expressing appropriate receptors. This leads to formation of heterokaryons, or syncytia, and potentially allows for the dissemination of the virus without the formation of mature virus particles. Nevertheless, in the majority of cases, the transfer of viral genomes from cell to cell appears to occur through the formation of virus particles that are released from infected cells and use the mechanisms described above to enter new uninfected hosts. Interestingly, the herpes virus varicella-zoster (VZV) appears to use cell-free viruses to spread from human to human but direct cell-to-cell transfer, without formation of infectious virions, to spread within an infected host ([@bib11]). Most studies of viral entry are, by necessity, conducted in tissue culture systems using cell lines that differ from the cells that are the normal targets for infection in vivo. Although these systems have contributed greatly to our understanding of virus entry, they do not fully replicate the in vivo scenario, and, as a consequence, crucial aspects of entry mechanisms may be missed.

In experimental systems, the entry stage of infection is usually studied by adding cell-free virus particles to cells. Often the efficiency of entry is low, and experimenters frequently enhance virus adsorption by including charged polymers, such as polybrene, in the medium or by gently centrifuging virus particles onto cells ([@bib55]). Viruses that have adapted to growing in tissue culture cells can show an enhanced tendency to use proteoglycans for initial recruitment to cell surfaces ([@bib17], [@bib97]). Indeed, HIV-1 strains adapted to grow in T cell lines appear to bind to cells via proteoglycans before engaging CD4 and coreceptors ([@bib94]). Together this suggests that the events involved in virus adsorption and entry in tissue culture may be different from those that occur in vivo. A number of recent studies suggest why this is the case.

Transmission of viruses from cell to cell in epithelial cells, for example, may occur through the basolateral domains, where a virus released from one cell can be effectively deposited on adjacent cells, minimizing the events associated with virus recruitment to the cell surface. Vaccinia virus (VV) provides an extreme example. VV is produced in several forms, of which the intracellular mature virus (IMV) and extracellular enveloped virus (EEV) are capable of infecting target cells. The EEV is initially assembled with three membranes and is released to the cell surface when the outer membrane fuses with the plasma membrane to produce an extracellular double-membraned particle. The EEV remains bound to the surface of the producer cell and induces the polymerization of cytoplasmic actin comets that push the virus around on the surface of the cell, often at the tips of filopodium-like projections ([@bib79], [@bib99]) (see [Figure 4](#fig4){ref-type="fig"} and [@bib25] \[this issue of *Cell*\]). In confluent cultures, and presumably in vivo as well, these projections push viruses into neighboring cells and enhance cell-to-cell transfer. Deletion of viral proteins involved in transmembrane signaling and actin nucleation reduces the viral plaque size in tissue culture and pathogenesis in vivo ([@bib79], [@bib99]).Figure 4Swine Pox Viruses at the Tip of Projections in the Plasma Membrane of the Infected CellAfter release from the cell, the viruses remain associated with the plasma membrane, where they induce assembly of actin filaments. The projections that are formed are motile and push the viruses into contact with neighboring cells. In this way, they promote infection within tissues. Note the actin filaments emanating from the area of virus cell contact. Courtesy of J. Kartenbeck. Scale bar = 500 nm.

Recently, structures termed infectious or virological synapses have been increasingly implicated in cell-to-cell virus transfer. Initially described for the transfer of the human T cell leukemia virus type 1 (HTLV-1) from infected to uninfected T cells, these areas of intimate contact between the infected and uninfected cells were recognized to have features in common with immunological synapses ([@bib30]). In contrast to T cell killing or antigen presentation, virological-synapse formation between T cells does not require major histocompatibility antigens ([@bib34]). The synapse provides a domain where virus assembly can be focused to release particles efficiently to a target cell. Similar means of transfer have been described for herpes viruses ([@bib33]) and for the T cell to T cell transfer of HIV ([@bib34]).

A particularly intriguing example of infectious synapse function is that described for dendritic cells. For many years it has been recognized that a highly efficient way of infecting T cells with HIV in culture is to first present the virus to dendritic cells ([@bib9]). HIV infection of dendritic cells can occur but is generally regarded as being inefficient. Recent studies have suggested an alternative mode of interaction whereby viruses may be captured by C type lectins ([@bib23], [@bib92]), and perhaps other receptors involved in antigen acquisition, and internalized into endocytic vesicles without infecting the dendritic cell. This virus can be regurgitated when dendritic cells interact with CD4-positive T cells and is able to infect the T cell in *trans* through infectious or virological synapses---a process that mimics the normal course of antigen presentation ([@bib51]). Viruses can be harbored in endocytic vesicles for hours, if not days, without losing infectivity, potentially allowing the dendritic cells in vivo to undergo maturation and relocation from peripheral tissue, where they would initially encounter viruses, to lymphoid organs. The endocytic compartment in which endocytosed viruses are sequestered is morphologically complex and bears some similarity to the compartments in macrophages where HIV assembles ([@bib22]). Although *trans*-infection has been documented in tissue culture, it remains unclear whether it operates in the same manner in vivo where, for HIV at least, infection of dendritic cells and the production of viruses in infected dendritic cells may be more relevant ([@bib93]). Regardless, the transfer of viruses through infectious synapses is likely to operate in both scenarios.

Similar dendritic-cell-mediated *trans-*infection routes have been proposed for a number of other viruses, including herpes, filo-, and flaviviruses ([@bib96]). Thus, these viruses have adapted to exploit a loophole in the defense strategies ranged against them by effectively using the cell\'s endocytosis and/or secretory mechanisms to allow their release to be temporally and spatially coordinated to focus infectious viruses on target cells. It is likely that similar strategies are used in various situations by different viruses; in particular, following reactivation of latent viruses, the transfer of HSV and varicella-zoster virus (chicken pox) from infected neurones to epithelial cells is likely to exploit specialized cell junctions ([@bib33]).

Thus, although the full life cycle of a virus requires assembly, dissemination by release from cells, and entry into new targets, the time during which viruses are genuinely cell free may be minimal. These mechanisms may limit the extent to which a virus is exposed to the humoral immune system ([@bib33]) and may also explain, for example, why, in HIV patients, infected T cells harbor multiple proviral genomes, suggestive of cells having undergone multiple, reasonably synchronous infection events ([@bib35]).

Viral Restriction {#sec1.9}
-----------------

Many viruses only infect a restricted range of cells, limiting their species tropism and cell tropism. Frequently, the restriction on infection is due to the absence of appropriate receptors. With retroviruses, however, a number of other mechanisms to limit viral replication have been discovered, and many of these operate at the level of entry ([@bib89]). For HIV in particular, several mechanisms have now been described through which virus replication can be limited independently of receptor expression. Cellular RNA-editing enzymes can be packaged into virus particles and can introduce mutations in the viral genome during the reverse-transcription event that occurs shortly after virus entry. HIV-1 uses its Vif protein to overcome this restriction by preventing packaging of the editing enzymes into virus particles ([@bib72]). In another example, the so-called Lv1 (or Ref1) restriction that prevents HIV-1 replication in Old World monkeys is mediated by a homo-oligomeric protein called Trim 5α ([@bib85], [@bib88]). Trim 5α appears to bind to an exposed loop on the capsid protein that becomes available when the capsid is released to the cytoplasm after fusion ([@bib100]). Trim 5α appears to prevent uncoating of the incoming particles by crosslinking the capsid protein subunits, though in some cases it may operate after reverse transcription ([@bib100]). The Fv1 restriction seen with murine leukemia viruses operates after reverse transcription and prevents nuclear entry ([@bib87]). Interestingly, the Fv1 restriction maps to an endogenous retroviral *gag* gene ([@bib5]), suggesting that interaction between incoming capsids and an endogenous Gag protein prevents infection.

In another form of restriction, now termed Lv2, some strains of HIV-1 and HIV-2 fail to replicate efficiently in HeLa cells. The phenotype maps to specific amino acids in both Env and capsids. For the Env-mediated restriction, at least, the failure to efficiently infect cells appears to be related to virus delivery to a raft-mediated endocytic pathway, and experimental manipulations that disrupt raft-mediated endocytosis overcome the restriction, as does diverting the virus to a clathrin-mediated pathway by pseudotyping the virus with the VSV-G protein ([@bib48], [@bib70]). Thus, not only must viruses find their way to the correct pathway for infection, but diversion to an alternative pathway, or blind alley, can limit the potential for subsequent infection and replication. Other mechanisms through which the mode of penetration determines the outcome of subsequent events in virus entry appear to operate for other related viruses ([@bib38]).

Perspectives {#sec1.10}
------------

Among the many challenges for the future is the need to identify exactly how many endocytic mechanisms contribute to virus entry and to determine which viruses use these pathways. RNAi screens similar to those described by [@bib63] will allow a systematic approach to these questions with the possibility that specific routes can be defined by the requirement for a unique set of genes and their encoded proteins. Thus, each endocytic mechanism might be given a unique genetic fingerprint. Understanding these processes may allow specific cellular pathways or molecular machines to be targeted pharmacologically to inhibit the entry of any virus that uses the route for infection. Such an approach may offer the advantage that it will be more difficult for a virus to find a way around the block by mutation. It will also be important to show that the pathways identified in tissue culture experiments operate in vivo during a normal infection. Such experiments will be difficult, especially with human viruses, but inhibitors identified through tissue culture experiments may make it possible to address these issues.

At the level of cells and virus particles, developments in morphological techniques from high-end light microscopy to electron microscopy are allowing the events involved in virus entry to be analyzed with increased spatial and temporal resolution. Single-particle tracking of virus particles containing components labeled with different fluorochromes or fluorescent proteins is allowing specific events to be followed in remarkable detail. For some viruses with high infectious-unit-to-particle ratios, such as SFV, such studies provide direct information on entry. More careful attention to the preparation and storage of other viruses may allow similar morphological experiments to be interpreted with the confidence that the events observed represent the behavior of infectious particles. The ability to use microscopes in high-throughput screens for inhibitors of virus entry or to determine key components in the entry pathway will have a far-reaching impact on our understanding of virus entry. Together, these studies should provide detailed insights to the cellular mechanisms of endocytosis. The identification of natural ligands will also be key in establishing the biological relevance of these pathways. If we revisit this topic in 5 years\' time, we will have a very much more detailed picture of virus entry. Viruses will continue to hold crucial cards in our attempts to understand cells and their pathogens.
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